Selena Gomez's Rare Beauty is coming to Ulta stores. 'It's happening.'

Rare Beauty, Selena Gomez's cosmetics company valued at $1.3 billion in June 2025, will begin selling products at Ulta Beauty stores starting Feb. 1, expanding distribution beyond its website and Sephora. Ulta has not disclosed which SKUs will be carried; the partnership should modestly increase Rare Beauty's retail reach and sales potential, reinforcing the brand's celebrity-driven growth and private-market valuation, but is unlikely to be materially market-moving for public companies.

Analysis

Market structure: Ulta (ULTA) is the clear beneficiary — expect a measurable but concentrated traffic/SKU uplift around the Feb 1 roll‑out. Model a 0.5–1.5% bump to same‑store sales in the first full quarter if Rare Beauty is merchandised chain‑wide, equating to ~1–3% incremental quarterly revenue contribution to a mid‑single‑digit revenue base; specialty e‑commerce pure‑plays and smaller prestige brands sold primarily at Sephora may cede share or see promotional pressure.

Risk assessment: Tail risks include celebrity reputational hit, supply shortages (inventory stocking ahead of launch), or unfavorable commercial terms (slotting/margin sharing) that compress ULTA gross margins by 10–50 bps. Timeline: immediate (days) — volatility/flow into ULTA; short (weeks–months) — measurable comp sales and margin impact; long (quarters–years) — brand distribution cadence and repeat purchase rates determine sustained benefit; key hidden dependency is in‑store vs online mix and SKU depth per store.

Trade implications: Direct: ULTA long favored pre‑launch to capture traffic lift; implement option overlays to size risk. Relative: pair trades long ULTA vs short larger prestige names with weaker retail expansion (e.g., EL) to hedge category cyclicality. Catalysts to monitor: Feb 1 launch, weekly comp sales updates, next ULTA earnings and management commentary on sell‑through and margin terms.

Contrarian angles: Consensus may overrate the structural upside — if Rare Beauty’s assortment at Ulta is limited, the stock pop will be transitory; historical celebrity beauty launches show strong initial velocity then reversion unless distribution+repeat rates are high. If ULTA rallies >10% on the news without corroborating comp data within 30–60 days, expect 5–8% mean reversion; downside from markdowns or slotting concessions could erase initial gains.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in ULTA ahead of the Feb 1 launch, scale 1/3 immediately and 2/3 in the week before launch; set a take‑profit at +12–15% within 3 months and a hard stop‑loss at −8% if same‑store sales do not improve by ≥0.5% in the first 60 days post‑launch.
• Buy a 45‑day ULTA call spread sized to 0.5–1.0% of portfolio (target delta ~0.40 long leg) expiring ~15–30 days after Feb 1 to capture post‑launch volatility; close on a 30–50% premium gain or if implied volatility falls by >20% from pre‑launch levels.
• Implement a pair trade: long ULTA (weight 1.0) vs short EL (Estee Lauder, weight 0.6) to isolate retail/traffic upside while hedging category cyclicality; rebalance after the first post‑launch earnings (expected within 60–90 days) or if ULTA comp sales beat by >1% (trim short EL).
• Avoid building new positions in small/mid cap DTC beauty stocks that rely on wholesale roll‑outs (allocate cash instead); if ULTA’s share jumps >10% on launch hype without matching comp/margin data in 30–60 days, take profits and redeploy into beaten‑down retail names with clearer fundamentals.